Table 3.
Model | Independent variables | R2 | F | β | P-value |
---|---|---|---|---|---|
Ethnicity | |||||
Model 1 | |||||
European-Americans | 0.301 | 13.0 | <0.001 | ||
Age (years) | 0.375 | <0.001 | |||
Gender (m/f) | − 0.237 | <0.001 | |||
LDL cholesterol (mg/dl) | 0.012 | NS | |||
HDL cholesterol (mg/dl) | − 0.035 | NS | |||
Triglyceride (mg/dl) | 0.002 | NS | |||
Waist circumference (cm) | − 0.001 | NS | |||
Hypertension (y/n) | 0.168 | 0.002 | |||
Smoking (y/n) | 0.158 | 0.002 | |||
ApoB/apoA-I | 0.112 | NS | |||
African-Americans | 0.225 | 6.8 | <0.001 | ||
Age (years) | 0.395 | <0.001 | |||
Gender (m/f) | − 0.042 | NS | |||
LDL cholesterol (mg/dl) | − 0.044 | NS | |||
HDL cholesterol (mg/dl) | 0.116 | NS | |||
Triglyceride (mg/dl) | 0.106 | NS | |||
Waist circumference (cm) | − 0.044 | NS | |||
Hypertension (y/n) | − 0.039 | NS | |||
Smoking (y/n) | 0.085 | NS | |||
ApoB/apoA-I | 0.335 | 0.014 | |||
Model 2 | |||||
European-Americans | 0.287 | 18.9 | <0.001 | ||
Age (years) | 0.395 | <0.001 | |||
Gender (m/f) | − 0.249 | <0.001 | |||
LDL cholesterol (mg/dl) | 0.014 | NS | |||
Smoking (y/n) | 0.156 | 0.003 | |||
Metabolic syndrome (y/n) | 0.114 | 0.037 | |||
ApoB/apoA-I | 0.126 | NS | |||
African-Americans | 0.209 | 9.5 | <0.001 | ||
Age (years) | 0.383 | <0.001 | |||
Gender (m/f) | − 0.049 | NS | |||
LDL cholesterol (mg/dl) | 0.014 | NS | |||
Smoking (y/n) | 0.097 | NS | |||
Metabolic syndrome (y/n) | 0.046 | NS | |||
ApoB/apoA-I | 0.242 | 0.011 |
Model 1; adjusted for age, gender, LDL and HDL cholesterol, triglycerides, waist circumference, hypertension, smoking and apoB/apoA-I ratio for both ethnic groups. Model 2; adjusted for Model 1 with an addition of metabolic syndrome for both ethnic groups. Apo, apolipoprotein; LDL, low-density lipoprotein; NS, non significant.